| Date Filed | Type | Description |
| 10/11/2019 |
4
| Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Bought 2,700 shares
@ $1.9613, valued at
$5.3k
|
|
| 09/06/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/30/2019 |
4
| Kelly Steven (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Granted 22,250 options to buy
@ $1.99, valued at
$44.3k
|
|
| 08/30/2019 |
4
| EMANUELE ROBERT MARTIN (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Granted 17,500 options to buy
@ $1.99, valued at
$34.8k
|
|
| 08/30/2019 |
4
| Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Granted 75,000 options to buy
@ $1.99, valued at
$149.3k
|
|
| 08/30/2019 |
4
| Erbez Georgia (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Granted 22,250 options to buy
@ $1.99, valued at
$44.3k
|
|
| 08/30/2019 |
4
| Blayney Douglas (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Granted 18,000 options to buy
@ $1.99, valued at
$35.8k
|
|
| 08/30/2019 |
4
| MATSUI CONNIE (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Granted 26,500 options to buy
@ $1.99, valued at
$52.7k
|
|
| 07/26/2019 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 07/15/2019 |
8-K
| Quarterly results |
| 07/15/2019 |
10-Q
| Quarterly Report for the period ended May 31, 2019 |
| 06/25/2019 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E... |
| 06/24/2019 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 06/21/2019 |
3
| EMANUELE ROBERT MARTIN (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC. |
| 06/21/2019 |
3
| Erbez Georgia (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC. |
| 06/21/2019 |
3
| Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 3 on ARTELO BIOSCIENCES, INC. |
| 06/21/2019 |
3
| Kelly Steven (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC. |
| 06/21/2019 |
3
| MATSUI CONNIE (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC. |
| 06/21/2019 |
3
| O'Brien Peter Michael (10% Owner) has filed a Form 3 on ARTELO BIOSCIENCES, INC. |
| 06/21/2019 |
3
| Moss David J (10% Owner) has filed a Form 3 on ARTELO BIOSCIENCES, INC. |
| 06/21/2019 |
3
| Blayney Douglas (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC. |
| 06/21/2019 |
CERT
| Form CERT - |
| 06/21/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/20/2019 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 06/10/2019 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 06/04/2019 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 06/04/2019 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 05/31/2019 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 05/29/2019 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 04/30/2019 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events |
| 04/15/2019 |
10-Q
| Quarterly Report for the period ended February 28, 2019 |
| 04/01/2019 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 02/11/2019 |
SC 13G/A
| Alinga Capital LLC reports a 7.2% stake in Artelo Biosciences Inc. |
| 01/14/2019 |
10-Q
| Quarterly Report for the period ended November 30, 2018 |
|